Drug intelligence / Profile preview

BR1016D

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

BR1016D is a code name for an investigational drug formulation evaluated in clinical trials to compare its pharmacokinetics and safety with another formulation, BR1016C, in healthy adults. The available information does not specify the active ingredient or mechanism of action for BR1016D. It is administered as a tablet in clinical studies, but no further details about its therapeutic class, target indications, or developer are provided[1][3].

Beyond the preview

Go deeper on BR1016D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BR1016D.

Explore the full profile